Cargando…

The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer

Over the last decade, investigators have developed a clearer understanding of the genetic alterations underlying thyroid carcinogenesis. A number of biomarkers involved in the pathogenesis of differentiated thyroid cancer have undergone intensive study, not only for their role in tumorigenesis, but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melck, Adrienne L., Yip, Linwah, Carty, Sally E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AlphaMed Press 2010
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227917/ https://www.ncbi.nlm.nih.gov/pubmed/21147872 http://dx.doi.org/10.1634/theoncologist.2010-0156

Ejemplares similares

Clinical Outcome, Role of BRAF(V600E), and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer?
por: Nucera, Carmelo, et al.
Publicado: (2012)

Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation
por: Han, Ying, et al.
Publicado: (2022)

Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer
por: Xia, Yuxiao, et al.
Publicado: (2022)

Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto’s thyroiditis: a systematic review with meta-analysis
por: Janicki, Lukasz, et al.
Publicado: (2023)

BRAF Testing in Multifocal Papillary Thyroid Carcinoma
por: Kimbrell, Hillary Z., et al.
Publicado: (2015)

Association Between Preoperative US, Elastography Features and Prognostic Factors of Papillary Thyroid Cancer With BRAF(V600E) Mutation
por: Xu, Jun-Mei, et al.
Publicado: (2020)

STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma
por: He, Weiman, et al.
Publicado: (2023)

Nomogram based on radiomics analysis of ultrasound images can improve preoperative BRAF mutation diagnosis for papillary thyroid microcarcinoma
por: Tang, Jiajia, et al.
Publicado: (2022)

The Combined Utility of HBME-1 and Galectin-3 Immunohistochemistry and BRAF V600E Mutations in the Diagnosis of Papillary Thyroid Carcinoma
por: Ramkumar, Subramaniam, et al.
Publicado: (2021)

BRAF in Papillary Thyroid Carcinoma
por: Lanzilotta, Salvatore Giovanni, et al.
Publicado: (2007)

The utility of sentinel Lymph node biopsy in the lateral neck in papillary thyroid carcinoma
por: Yan, Xing-qiang, et al.
Publicado: (2022)

OR32-06 Disease-related Outcomes In Patients With Thyroid Cancer On Long Term Follow-up: Analysis Of 1487 Patients
por: Doerfler, William R, et al.
Publicado: (2023)

Radiomic Model for Determining the Value of Elasticity and Grayscale Ultrasound Diagnoses for Predicting BRAF(V600E) Mutations in Papillary Thyroid Carcinoma
por: Wang, Yu-guo, et al.
Publicado: (2022)

BRAF(V600E) Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT
por: Gao, Yuan, et al.
Publicado: (2022)

Papillary Thyroid Carcinoma and Inflammation
por: Fugazzola, Laura, et al.
Publicado: (2011)

Mouse Models of Follicular and Papillary Thyroid Cancer Progression
por: Russo, Marika A., et al.
Publicado: (2012)

Rethinking the Role of Oncogenes in Papillary Thyroid Cancer Initiation
por: Vitale, Mario
Publicado: (2012)

Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer
por: Podetta, Michele, et al.
Publicado: (2018)

Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Braf(v600e) Mutation: A Single Center Study of 1,207 Chinese Patients
por: Xue, Shuai, et al.
Publicado: (2019)

Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib
por: Jafri, Sabih, et al.
Publicado: (2021)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

Cost Impact of Molecular Testing for Indeterminate Thyroid Nodule Fine-Needle Aspiration Biopsies
por: Yip, Linwah, et al.
Publicado: (2012)

Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto’s Thyroiditis
por: Min, Yu, et al.
Publicado: (2021)

Fine Needle Biopsy Versus Core Needle Biopsy Combined With/Without Thyroglobulin or BRAF 600E Mutation Assessment for Detecting Cervical Nodal Metastasis of Papillary Thyroid Carcinoma
por: Zhang, Xiaojun, et al.
Publicado: (2021)

Prognostication of papillary thyroid microcarcinoma based on preoperative ultrasound
por: Cohen, Samuel M., et al.
Publicado: (2023)

Thirty synchronous medullary and papillary thyroid carcinomas
por: Zhang, Daqi, et al.
Publicado: (2023)

Clinical Relevance and Management of Recurrent Laryngeal Nerve Inlet Zone Lymph Nodes Metastasis in Papillary Thyroid Cancer
por: Zheng, Guibin, et al.
Publicado: (2021)

MON-LB79 Do Ultrasound Patterns and Clinical Parameters Modify the Probability of Thyroid Cancer Predicted by Molecular Testing in Thyroid Nodules With Indeterminate Cytology?
por: Figge, James J, et al.
Publicado: (2020)

Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis
por: Hescheler, Daniel A., et al.
Publicado: (2021)

Establishment of papillary thyroid cancer organoid lines from clinical specimens
por: Yang, Hao, et al.
Publicado: (2023)

Immunohistochemical Analysis of Cancer Stem Cell Marker Expression in Papillary Thyroid Cancer
por: Kim, Hye Min, et al.
Publicado: (2019)

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly
por: Kim, Hee Kyung, et al.
Publicado: (2014)

Long-Term Oncological Outcomes of Papillary Thyroid Cancer and Follicular Thyroid Cancer in Children: A Nationwide Population-Based Study
por: van de Berg, Daniël J., et al.
Publicado: (2022)

Ultrasonographic Features of Papillary Thyroid Carcinomas According to Their Subtypes
por: Baek, Hye Jin, et al.
Publicado: (2018)

Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects
por: Xue, Shuai, et al.
Publicado: (2018)

Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment
por: Xie, Zhenyu, et al.
Publicado: (2020)

Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence
por: de Castro, Taciana Padilha, et al.
Publicado: (2019)

Extent of Surgery and the Prognosis of Unilateral Papillary Thyroid Microcarcinoma
por: Zhao, Hengqiang, et al.
Publicado: (2021)

A clinically useful and biologically informative genomic classifier for papillary thyroid cancer
por: Craig, Steven, et al.
Publicado: (2023)

BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry
por: Estrada-Flórez, Ana P, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bv69bgq1d4b5nc6dja4df78utg